MedTrace Logo

Trans-theoretical Model Based Home Visiting on Medication Behavior

NCT05951062 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-07-18

No results posted yet for this study

Summary

This study was a single-blinded, two-armed, randomized controlled trial comparing a medication self-management intervention to usual care for hypertensive elderly in the residential care facility.

To explore the effect of stage-matched tailored education on disease management for hypertensive elderly. Patient were randomly assigned to either a 6-month trans-theoretical model-based medication management intervention group or a treatment-as-usual group. we would like to improve its adherence to the medicine prescribed by their own physician through five sessions of face-to-face interview which focused on anti-hypertensive medication-related information, the importance of medication refills, motivation, self-management and self-check skills.

Conditions

Interventions

BEHAVIORAL

behavior management for anti-hypertensive medication

five sessions of educational interview and home visiting to improve medication-related self-management skills

OTHER

placebo group

treatment as usual

Sponsors & Collaborators

  • Jing Chang

    lead OTHER

Principal Investigators

  • Jing Chang, Master · The First Affiliated Hospital of Zhengzhou University，Zhengzhou,China. ZIP：450000

  • YiJing Chen, Master · Wuhan mental health center,Wuhan,China. ZIP：430000

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2022-10-01
Completion
2022-10-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05951062 on ClinicalTrials.gov